Cooperation between Different CRISPR-Cas Types Enables Adaptation in an RNA-Targeting System

被引:24
|
作者
Hoikkala, Ville [1 ]
Ravantti, Janne [2 ]
Diez-Villasenor, Cesar [1 ]
Tiirola, Marja [1 ]
Conrad, Rachel A. [3 ]
McBride, Mark J. [3 ]
Moineau, Sylvain [4 ]
Sundberg, Lotta-Riina [1 ]
机构
[1] Univ Jyvaskyla, Nanosci Ctr, Dept Biol & Environm Sci, Jyvaskyla, Finland
[2] Univ Helsinki, Mol & Integrat Biosci Res Programme, Helsinki, Finland
[3] Univ Wisconsin, Dept Biol Sci, POB 413, Milwaukee, WI 53201 USA
[4] Univ Laval, Dept Biochim Microbiol & Bioinformat, Quebec City, PQ, Canada
来源
MBIO | 2021年 / 12卷 / 02期
基金
加拿大自然科学与工程研究理事会; 芬兰科学院;
关键词
CRISPR; adaptation; bacteriophages; coevolution; spacer acquisition; type II; type VI; SPACER ACQUISITION; IMMUNE-SYSTEMS; DNA; CLASSIFICATION; EVOLUTION; PROTEINS; CLEAVAGE; PHAGE; GENERATION; RESISTANCE;
D O I
10.1128/mBio.03338-20
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
CRISPR-Cas immune systems adapt to new threats by acquiring new spacers from invading nucleic acids such as phage genomes. However, some CRISPR-Cas loci lack genes necessary for spacer acquisition despite variation in spacer content between microbial strains. It has been suggested that such loci may use acquisition machinery from cooccurring CRISPR-Cas systems within the same strain. Here, following infection by a virulent phage with a double-stranded DNA (dsDNA) genome, we observed spacer acquisition in the native host Flavobacterium columnare that carries an acquisition-deficient CRISPR-Cas subtype VI-B system and a complete subtype II-C system. We show that the VI-B locus acquires spacers from both the bacterial and phage genomes, while the newly acquired II-C spacers mainly target the viral genome. Both loci preferably target the terminal end of the phage genome, with priming-like patterns around a preexisting II-C protospacer. Through gene deletion, we show that the RNA-cleaving VI-B system acquires spacers in trans using acquisition machinery from the DNA-cleaving II-C system. Our observations support the concept of cross talk between CRISPR-Cas systems and raise further questions regarding the plasticity of adaptation modules. IMPORTANCE CRISPR-Cas systems are immune systems that protect bacteria and archaea against their viruses, bacteriophages. Immunity is achieved through the acquisition of short DNA fragments from the viral invader's genome. These fragments, called spacers, are integrated into a memory bank on the bacterial genome called the CRISPR array. The spacers allow for the recognition of the same invader upon subsequent infection. Most CRISPR-Cas systems target DNA, but recently, systems that exclusively target RNA have been discovered. RNA-targeting CRISPR-Cas systems often lack genes necessary for spacer acquisition, and it is thus unknown how new spacers are acquired and if they can be acquired from DNA phages. Here, we show that an RNA-targeting system "borrows" acquisition machinery from another CRISPR-Cas locus in the genome. Most new spacers in this locus are unable to target phage mRNA and are therefore likely redundant. Our results reveal collaboration between distinct CRISPR-Cas types and raise further questions on how other CRISPR-Cas loci may cooperate.
引用
下载
收藏
页数:18
相关论文
共 50 条
  • [41] A seed motif for target RNA capture enables efficient immune defence by a type III-B CRISPR-Cas system
    Pan, Saifu
    Li, Qi
    Deng, Ling
    Jiang, Suping
    Jin, Xuexia
    Peng, Nan
    Liang, Yunxiang
    She, Qunxin
    Li, Yingjun
    RNA BIOLOGY, 2019, 16 (09) : 1166 - 1178
  • [42] CRISPR-Cas: Evolution of an RNA-based adaptive immunity system in prokaryotes
    Koonin, Eugene V.
    Makarova, Kira S.
    RNA BIOLOGY, 2013, 10 (05) : 679 - 686
  • [43] The CRISPR-Cas system: small RNA-guided invader silencing in prokaryotes
    Terns, Becky
    Hale, Caryn
    Carte, Jason
    Elmore, Joshua
    Majumdar, Sonali
    Glover, Claiborne V. C., III
    Graveley, Brenton
    Terns, Michael
    FASEB JOURNAL, 2012, 26
  • [44] A CRISPR-Cas and Tat Peptide with Fluorescent RNA Aptamer System for Signal Amplification in RNA Imaging
    Tang, Heng
    Peng, Junran
    Jiang, Xin
    Peng, Shuang
    Wang, Fang
    Weng, Xiaocheng
    Zhou, Xiang
    BIOSENSORS-BASEL, 2023, 13 (02):
  • [45] An RNA-targeting CRISPR–Cas13d system alleviates disease-related phenotypes in Huntington’s disease models
    Kathryn H. Morelli
    Qian Wu
    Maya L. Gosztyla
    Hongshuai Liu
    Minmin Yao
    Chuangchuang Zhang
    Jiaxu Chen
    Ryan J. Marina
    Kari Lee
    Krysten L. Jones
    Megan Y. Huang
    Allison Li
    Charlene Smith-Geater
    Leslie M. Thompson
    Wenzhen Duan
    Gene W. Yeo
    Nature Neuroscience, 2023, 26 : 27 - 38
  • [46] An RNA-targeting CRISPR-Cas13d system alleviates disease-related phenotypes in Huntington's disease models
    Morelli, Kathryn H.
    Wu, Qian
    Gosztyla, Maya L.
    Liu, Hongshuai
    Yao, Minmin
    Zhang, Chuangchuang
    Chen, Jiaxu
    Marina, Ryan J.
    Lee, Kari
    Jones, Krysten L.
    Huang, Megan Y.
    Li, Allison
    Smith-Geater, Charlene
    Thompson, Leslie M.
    Duan, Wenzhen
    Yeo, Gene W.
    NATURE NEUROSCIENCE, 2023, 26 (01) : 27 - +
  • [47] Optimized RNA-targeting CRISPR/Cas13d technology outperforms shRNA in identifying functional circRNAs
    Zhang, Yang
    Nguyen, Tuan M.
    Zhang, Xiao-Ou
    Wang, Limei
    Phan, Tin
    Clohessy, John G.
    Pandolfi, Pier Paolo
    GENOME BIOLOGY, 2021, 22 (01)
  • [48] Optimized RNA-targeting CRISPR/Cas13d technology outperforms shRNA in identifying functional circRNAs
    Yang Zhang
    Tuan M. Nguyen
    Xiao-Ou Zhang
    Limei Wang
    Tin Phan
    John G. Clohessy
    Pier Paolo Pandolfi
    Genome Biology, 22
  • [49] SCOPE enables type III CRISPR-Cas diagnostics using flexible targeting and stringent CARF ribonuclease activation
    Steens, Jurre A.
    Zhu, Yifan
    Taylor, David W.
    Bravo, Jack P. K.
    Prinsen, Stijn H. P.
    Schoen, Cor D.
    Keijser, Bart J. F.
    Ossendrijver, Michel
    Hofstra, L. Marije
    Brouns, Stan J. J.
    Shinkai, Akeo
    van der Oost, John
    Staals, Raymond H. J.
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [50] SCOPE enables type III CRISPR-Cas diagnostics using flexible targeting and stringent CARF ribonuclease activation
    Jurre A. Steens
    Yifan Zhu
    David W. Taylor
    Jack P. K. Bravo
    Stijn H. P. Prinsen
    Cor D. Schoen
    Bart J. F. Keijser
    Michel Ossendrijver
    L. Marije Hofstra
    Stan J. J. Brouns
    Akeo Shinkai
    John van der Oost
    Raymond H. J. Staals
    Nature Communications, 12